Enter the first few characters of Company and click 'Go'
Quarterly Results of GlaxoSmithKline Pharmaceuticals Ltd. Company(Figures in Rs crores)
|
|
Dec 31, 2023 |
Sep 30, 2023 |
Jun 30, 2023 |
Mar 31, 2023 |
Dec 31, 2022 |
Net Sales / Income |
804.98 |
953.38 |
738.02 |
782.16 |
799.11 |
Other Income |
28.34 |
28.47 |
36.80 |
27.97 |
23.60 |
Net Profit/Loss |
45.49 |
215.54 |
130.58 |
131.48 |
164.03 |
Raw Material |
87.52 |
79.71 |
145.47 |
95.70 |
43.12 |
Power And Fuel |
0 |
0 |
0 |
0 |
0 |
Employee Expenses |
141.35 |
145.21 |
165 |
148.84 |
152.99 |
Excise |
|
|
|
|
|
Admin And Selling Expenses |
0 |
0 |
0 |
0 |
0 |
Research And Devlopment Expenses |
0 |
0 |
0 |
0 |
0 |
Expenses Capitalised |
0 |
0 |
0 |
0 |
0 |
Other Expenses |
294.67 |
432.17 |
330.68 |
301.52 |
260.43 |
Provisions Made |
0 |
0 |
0 |
0 |
0 |
Interest |
0.32 |
0.43 |
0.28 |
0.65 |
0.09 |
Gross Profit |
245.53 |
314.62 |
177.77 |
194.08 |
251.31 |
Depreciation |
17.11 |
18.11 |
16.36 |
17.18 |
16.41 |
Taxation |
19.62 |
80.97 |
48.13 |
55.82 |
59.50 |
Extra Ordinary Item |
-163.31 |
0 |
17.30 |
10.40 |
-11.37 |
Prior Year Adjustments |
0 |
0 |
0 |
0 |
0 |
Equity Capital |
169.41 |
169.41 |
169.41 |
169.41 |
169.41 |
Equity Dividend Rate |
0 |
0 |
0 |
0 |
0 |
Agg.Of Non-Prom. Shares (in lacs) |
0 |
0 |
0 |
0 |
0 |
Agg.Of Non PromotoHolding (%) |
0 |
0 |
0 |
0 |
0 |
EPS (in Rs.) |
2.69 |
12.72 |
7.71 |
7.76 |
9.68 |
|
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article